Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @mlazaru
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @mlazaru
-
This is a material De-Risking event. Next up Unituxin read out, fingers crossed!
$UTHR - biotech with free cash flow, mis understood generic cliff. Ralinepag best in class asset on the come, and remodulin franchise remains intact. Orenitram and Tyvaso growinghttps://twitter.com/PunditPatent/status/1222583363539742721 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
$CBIO DalcA EAHAD abstract. Zero EV for big market opportunity in Hem. https://onlinelibrary.wiley.com/doi/pdf/10.1111/hae.13910 … no neutralizing antibodies. More to come in compliment.$BIIB called out$CBIO at#JPM20 as area or excitement. I repeat ZERO EV in DalcA programHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
$JBLU This makes complete sense. Long Jet Blue! Great interview, worth the 2 minutes to watch. On valuation Jet Blue is accretive to$LUV as well. Great interview Joseph Denardi!https://twitter.com/CNBCTheExchange/status/1220097822869065730 …
2:42Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
mathew lazarus proslijedio/la je Tweet
$NK and ImmunityBio; Complete Response in Metastatic Pancreatic Cancer in the First Patient to Receive PD-L1 Tumor-Targeted NK Cells Combined with N-803 IL-15 Fusion Proteinhttps://www.businesswire.com/news/home/20200114005307/en/NantKwest-ImmunityBio-Announce-Complete-Response-Metastatic-Pancreatic …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
$NK- "Based on these encouraging findings, we plan to initiate clinical trials to confirm efficacy in second-line metastatic pancreatic cancer and third-line Triple Negative Breast cancer.”https://ir.nantkwest.com/news-releases/news-release-details/nantkwest-and-immunitybio-announce-complete-response-metastatic?field_nir_news_date_value[min]= …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
$NK - triangle offense: https://www.youtube.com/watch?v=zHK66f8sGfA …#JPM20 patients live longer on NK cellHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
"We believe ADVM-022 has the potential to be a paradigm-changing treatment for patients with wet AMD and for patients with diabetic retinopathy"
$ADVM#oneanddone#JPM20 gene therapy cureshttps://twitter.com/odibro/status/1216495832687685632 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
$ADVM 52 week injection free, no safety issues. Continued excellent data from Adverum.#JPM20http://investors.adverum.com/news-releases/news-release-details/adverum-biotechnologies-reports-additional-clinical-data-first-0 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
mathew lazarus proslijedio/la je Tweet
2016: Patrick Soon-Shiong vows to transform cancer treatment by 2020 2020: Not much has happened, as
@RebeccaDRobbins reports after digging into PSS’s cancer efforts. Great story:https://www.statnews.com/2020/01/08/patrick-soon-shiong-2020-cancer-moonshot/ …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
$NK - looking forward to this....#JPM20#JPM2020https://twitter.com/DrPatSoonShiong/status/1214623284718780416 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
mathew lazarus proslijedio/la je Tweet
The
$SWTX combo preclinical data show promise. DREAMM-5 may be their ticket here.Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
$SWTX - the big winner from todays$GSK BCMA data. Combo Trial planned. Gamma Secretase Inhibitor enhances activity...... https://ir.springworkstx.com/news-releases/news-release-details/researchers-present-preclinical-data-showing-synergistic …#springworks#BCMAHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
$NK-3rd w CR?!"2 out of 9 patients to date have ongoing complete responses with durations ranging from 8 to 11 months, with a 3rd patient demonstrating a partial response (near complete response) in the target lesion after initiation of targeted and endocrine therapy offstudy"Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
mathew lazarus proslijedio/la je Tweet
Join us for a discussion of head gear on
@CBSSports#ArmyNavyGame Pregame! @JonesN4mo @CoachNeuheiselpic.twitter.com/XdMpH83KPG
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
$NK -#TNBC poster from San Antonio: 78% Disease Control Rate(DCR) , 22% Complete Responder (CR), 67%(ORR)!#SABCS19 - https://nantkwest.com/wp-content/uploads/2019/12/SABCS-TNBC-NCV-2019.pdf …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
mathew lazarus proslijedio/la je Tweet
We are pleased to announce updated clinical data on MB-107 lentiviral gene therapy for
#XSCID presented at#ASH2019 by@StJudeResearch and@NIH http://ir.mustangbio.com/file/Index?KeyFile=401480311 …$MBIOHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
$SPCE - your spaceship is about to blast off.... HiHOHiHOHiHO:https://www.youtube.com/watch?v=ieddjSFFuCU …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
mathew lazarus proslijedio/la je Tweet
Lp(a) Major Risk Factor for Heart Disease. Big news out of deCODE regarding Lp(a). Directly relevant to
$ARWR's AMG 890, that targets Lp(a), licensed to$AMGN. Must be leading up to something big coming out soon.#RNAi#biotech#GameOnhttps://www.prnewswire.com/news-releases/beyond-cholesterol-landmark-decode-study-elucidates-role-of-lipoproteina-as-major-risk-factor-for-heart-disease-300971592.html …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
$NK - dear market, take a look at this abstract, will be presented at San Antonio next week. Triple Negative Breast Cancer data: Too good to ignore, https://www.abstractsonline.com/pp8/#!/7946/presentation/1378 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.